Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Two U.S. luxury houses and the FTC are set to battle in court to reach a final decision that will change the market.
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback